Document:

Registration Rights Agreement

 Exhibit 4.4 

 
  
 REGISTRATION RIGHTS AGREEMENT 
 by and among 

SPANSION INC. 
 and 
 THE HOLDERS NAMED HEREIN 

 
  

Dated as of May 3, 2010 
  

 
  

 

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
		
	 1.      Definitions
	  	 	1	  
		
	 2.      Securities Act Registration on Request
	  	 	4	  
		
	 3.      Piggyback Registration
	  	 	9	  
		
	 4.      Expenses
	  	 	10	  
		
	 5.      Registration Procedures
	  	 	10	  
		
	 6.      Underwritten Offerings
	  	 	15	  
		
	 7.      Preparation: Reasonable Investigation
	  	 	17	  
		
	 8.      Postponements
	  	 	18	  
		
	 9.      Indemnification
	  	 	19	  
		
	 10.    Registration Rights to Others
	  	 	21	  
		
	 11.    Adjustments Affecting Registrable Common Stock
	  	 	22	  
		
	 12.    Rule 144 and Rule 144A; Listing
	  	 	22	  
		
	 13.    Amendments and Waivers
	  	 	22	  
		
	 14.    Nominees for Beneficial Owners
	  	 	23	  
		
	 15.    Assignment
	  	 	23	  
		
	 16.    Calculation of Percentage or Number of Shares of Registrable Common Stock
	  	 	23	  
		
	 17.    Termination of Registration Rights
	  	 	24	  
		
	 18.    Miscellaneous
	  	 	24	  
		
	 19.    Transfer Agent
	  	 	25	  
		
	 SCHEDULE A – NOTICES
	  			
		
	 EXHIBIT A – FORM OF SELLING STOCKHOLDER QUESTIONNAIRE
	  			

  
 i 

 REGISTRATION RIGHTS AGREEMENT 

This REGISTRATION RIGHTS AGREEMENT, dated as of May 3, 2010 (this “Agreement”), is entered into by and among
Spansion Inc., a Delaware corporation (the “Company”), and each of the signatories hereto under the heading “Holders” (individually, a “Holder” and, collectively, the “Holders”).

 WHEREAS, this Agreement is being entered into in connection with the Backstop Rights Purchase Agreement entered into by and
among the Company and the Holders and dated as of January 25, 2010 (the “Backstop Agreement”) and the acquisition of Common Stock (as hereinafter defined) on the date hereof by the Holders pursuant to the Backstop Agreement and
the Plan (as hereinafter defined); and 
 WHEREAS, it is a condition precedent to providing the backstop commitment to the
Company under the Backstop Agreement that the Company shall have executed and delivered to the Holders this Agreement; and 

WHEREAS, to induce the Holders to provide the backstop commitment under the Backstop Agreement and the Plan, the Company has undertaken
to register Registrable Common Stock (as hereinafter defined) under the Securities Act (as hereinafter defined) and to take certain other actions with respect to the Registrable Common Stock. This Agreement sets forth the terms and conditions of
such undertaking. 
 NOW, THEREFORE, in consideration of the premises and the mutual agreements set forth herein, the parties
hereto hereby agree as follows: 
 1. Definitions. Unless otherwise defined herein, capitalized terms used herein and in
the recitals above shall have the following meanings: 
 “Affiliate” of a Person means any Person that
directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such other Person. For purposes of this definition, “control” means the ability of one Person to direct the
management and policies of another Person. 
 “Agreement” has the meaning set forth in the preamble hereto.

 “beneficial ownership” (and related terms such as “beneficially owned” or “beneficial
owner”) has the meaning set forth in Rule 13d-3 under the Exchange Act. 
 “Board of Directors” means the
board of directors of the Company. 
 “Business Day” means any day except a Saturday, Sunday or other day on
which commercial banks in New York City are authorized or required by law to be closed. 
 “Class B Common
Stock” means the shares of common stock of the Company classified as “Class B Common Stock” that the Holders, at their election, have the right to receive in lieu of Common Stock. 

 “Commission” means the U.S. Securities and Exchange Commission. 

“Common Stock” means the common stock, par value $0.01 per share, of the Company. 

“Company” has the meaning set forth in the preamble hereto. 

“Company Indemnitee” has the meaning set forth in Section 9(a) hereof. 

“Effective Date” means the effective date of the Plan pursuant to the terms thereof. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, or any
similar or successor statute. 
 “Expenses” means all expenses incident to the Company’s performance of or
compliance with its obligations under this Agreement, including, without limitation, all registration, filing, listing, stock exchange and FINRA fees (including, without limitation, all fees and expenses of any “qualified independent
underwriter” required by the rules of FINRA), all fees and expenses of complying with state securities or blue sky laws (including, without limitation, the reasonable fees, disbursements and other charges of counsel for the underwriters in
connection with blue sky filings), all word processing, duplicating and printing expenses, messenger, telephone and delivery expenses, all rating agency fees, the fees, disbursements and other charges of counsel for the Company and of its
independent public accountants, including, without limitation, the expenses incurred in connection with “cold comfort” letters required by or incident to such performance and compliance, the fees and expenses incurred in connection with
the listing of the securities to be registered on each securities exchange or national market system on which similar securities issued by the Company are then listed, any fees and disbursements of underwriters customarily paid by issuers or sellers
of securities, the reasonable fees, disbursements and other charges (not to exceed $30,000 in the aggregate for all jurisdictions) of one firm of counsel in each applicable jurisdiction (per registration statement prepared) to the Holders making a
request pursuant to Section 2(a), Section 2(i) or Section 3 hereof (selected by the Holders beneficially owning a majority of the shares of Registrable Common Stock covered by such registration), the fees and expenses of any special
experts retained by the Company in connection with such registration, and the fees and expenses of other Persons retained by the Company, but excluding underwriting discounts and commissions and applicable transfer taxes, if any, in each case
relating to the shares of Registrable Common Stock sold by the Selling Holders, which discounts, commissions and transfer taxes shall be borne by the seller or Selling Holders. 

“FINRA” shall mean the Financial Industry Regulatory Authority. 

“Form S-3 Request” has the meaning set forth in Section 2(i) hereof. 

“Holder Indemnitee” has the meaning set forth in Section 9(b) hereof. 

“Holder” and “Holders” have the meanings set forth in the preamble hereto. 

  
 2 

 “Initiating Form S-3 Holder” has the meaning set forth in Section 2(i)
hereof. 
 “Initiating Holder” has the meaning set forth in Section 2(a) hereof. 

“Initiating Request” has the meaning set forth in Section 2(a) hereof. 

“Loss” and “Losses” have the meanings set forth in Section 9(a) hereof. 

“Offering Documents” has the meaning set forth in Section 9(a) hereof. 

“Person” means any individual, corporation, partnership, limited liability company, firm, joint venture, association,
joint stock company, trust, unincorporated organization, governmental or regulatory body or subdivision thereof or other entity. 
 “Piggyback Requesting Holder” has the meaning set forth in Section 3 hereof. 
 “Plan” means the Second Amended Joint Plan of Reorganization for the Debtors filed with the United States Bankruptcy Court for the District of Delaware, dated December 16, 2009, in
the chapter 11 case commenced by the Company and certain of its Subsidiaries. 
 “Public Offering” means a
public offering and sale of Common Stock pursuant to an effective registration statement under the Securities Act. 

“Questionnaire” has the meaning set forth in Section 2(h) hereof. 

“Registrable Common Stock” means any share of Common Stock acquired pursuant to the Backstop Agreement, the Rights
Offering (as defined in the Plan) or otherwise in accordance with the Plan, and beneficially owned by the Holders from time to time, including shares of Class B Common Stock which are convertible into Common Stock; provided, however,
that a share of Common Stock will cease to be Registrable Common Stock after it has been sold under a registration statement effected pursuant hereto or may be sold pursuant to Rule 144 promulgated under the Securities Act. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar
or successor statute. 
 “Selling Holders” means the Holders requesting to be registered pursuant hereto.

 “Shelf Registration” means a registration effected pursuant to a Shelf Registration Statement. 

“Shelf Registration Statement” means a shelf registration statement, as may be amended or supplemented from time to
time, filed pursuant to Rule 415 promulgated under the Securities Act. 
 “Subsidiary” shall mean, with respect
to any Person, any corporation, limited liability company, partnership, association or other business entity of which fifty percent (50%) or more of the total voting power of shares of capital stock entitled (without regard to the

  
 3 

 
occurrence of any contingency) to vote generally in the election of directors, managers or trustees thereof, or fifty percent (50%) or more of the equity interest therein, is at the time
owned or controlled, directly or indirectly, by any Person or one or more of the other Subsidiaries of such Person or a combination thereof. 
 “Transfer” means any direct or indirect transfer, sale, offer, assignment, exchange, distribution, mortgage, pledge, hypothecation or other disposition. “Transferor” and
“Transferee” have correlative meanings. 
 2. Securities Act Registration on Request. 

(a) Request. At any time after ninety (90) days following the Effective Date, and from time to time thereafter prior to the
termination of the Company’s obligations hereunder pursuant to and in accordance with the terms of Section 17 hereof, any Holder (the “Initiating Holder”) may make a written request (the “Initiating
Request”) to the Company for the registration with the Commission under the Securities Act (on Form S-3 or, if Form S-3 is not then available to the Company, Form S-1 or any other appropriate form) of all or part of the Initiating
Holder’s Registrable Common Stock, which request shall specify the number of shares to be disposed of by the Initiating Holder, the proposed plan of distribution therefor and whether or not a Shelf Registration Statement is being requested
(subject to the conditions of Section 2(g)). Upon the receipt of any Initiating Request for registration pursuant to this Section 2(a), the Company promptly shall notify in writing all other Holders of the receipt of such request and will
use its commercially reasonable efforts to effect, at the earliest practicable date, such registration under the Securities Act of: 
 (i) the Registrable Common Stock which the Company has been so requested to register by the Initiating Holder, and 
 (ii) all other Registrable Common Stock which the Company has been requested to register by any other Holders by written request given to the Company within twenty (20) days after the giving of
written notice by the Company to such other Holders of the Initiating Request (or ten (10) days if the Company states in such written notice or gives telephonic notice to such other Holders, with written confirmation to follow promptly
thereafter, stating that (i) such registration will be on Form S-3 (or, if Form S-3 is not then available to the Company, Form S-1 or any other appropriate form) and (ii) such shorter period of time is required because of a planned filing
date), 
 all to the extent necessary to permit the disposition (in accordance with Section 2(c) hereof) of the Registrable Common Stock to
be so registered; provided, that, 
 (A) the Company shall not be required to effect more than a
total of three (3) registrations pursuant to this Section 2(a) for all Holders, 
 (B) if the intended
method of distribution is an underwritten Public Offering, the Company shall not be required to effect such registration pursuant to this Section 2(a) unless such underwriting shall be conducted on a “firm commitment” basis,

  
 4 

 (C) if the Company shall have previously effected a registration pursuant
to this Section 2(a), the Company shall not be required to effect any registration pursuant to this Section 2(a) until a period of one hundred eighty (180) days shall have elapsed from the date on which the previous such registration
ceased to be effective, 
 (D) any Selling Holder whose Registrable Common Stock was to be included in any such
registration pursuant to this Section 2(a), by written notice to the Company, may withdraw such request, and the Company shall not effect such registration in the event that the Selling Holders that have not elected to withdraw beneficially
own, in the aggregate, less than the percentage of the shares of Registrable Common Stock required to initiate a request under this Section 2(a), and 
 (E) a Shelf Registration effected under this Section 2(a) shall comply with the procedures set forth in Section 2(h). 
 (b) Registration of Other Securities. Whenever the Company shall effect a registration pursuant to Section 2(a) hereof, no securities other than (i) Registrable Common Stock and
(ii) subject to Section 2(f), Common Stock to be sold by the Company for its own account shall be included among the securities covered by such registration unless the Selling Holders beneficially owning not less than a majority of the
shares of Registrable Common Stock to be covered by such registration shall have consented in writing to the inclusion of such other securities; provided, that, for the avoidance of doubt, nothing in this Section 2(b) shall prevent the Company
from registering Common Stock to be sold by the Company for its own account pursuant to other registration statements. 
 (c)
Registration Statement Form. Except as provided in Section 2(a), registrations under Section 2(a) hereof shall be on such appropriate registration statement form prescribed by the Commission under the Securities Act as shall be
selected by the Company and as shall permit the disposition of the Registrable Common Stock pursuant to an underwritten offering unless the Selling Holders beneficially owning at least a majority of the shares of Registrable Common Stock requested
to be included in such registration statement determine otherwise, in which case pursuant to the method of distribution reasonably determined by such Selling Holders. The Company agrees to include in any such registration statement filed pursuant to
Section 2(a) hereof all information which the Selling Holders beneficially owning at least a majority of shares of the Registrable Common Stock covered by such registration statement effected pursuant hereto, upon advice of counsel as being
required to be included in the registration statement, shall reasonably request. The Company shall use its commercially reasonable efforts to become eligible to use Form S-3 and, after becoming eligible to use Form S-3, shall use its commercially
reasonable efforts to remain eligible to use Form S-3. 
 (d) Effective Registration Statement. A registration requested
pursuant to Section 2(a) hereof shall not be deemed to have been effected: 
 (i) unless a registration
statement with respect thereto has been declared effective by the Commission and remains effective in compliance with the 

  
 5 

 
provisions of the Securities Act and the laws of any state or other jurisdiction applicable to the disposition of Registrable Common Stock covered by such registration statement until such time
as all of such Registrable Common Stock have been disposed of in accordance with such registration statement or there shall cease to be any Registrable Common Stock covered by such registration statement, provided, that, except with
respect to any Shelf Registration, such period need not exceed ninety (90) days (plus a number of Business Days equal to the number of Business Days, if any, that the registration statement is not kept effective (including any days for which
the use of the prospectus is suspended pursuant to Section 8(b)) after the initial date of its effectiveness and prior to the expiration of such ninety (90) day period), and, provided, further, that with respect to any Shelf
Registration, such period need not extend beyond the period provided for in Section 2(g) hereof, 
 (ii) if,
after it has become effective, such registration is subject to any stop order, injunction or other order or requirement of the Commission or other governmental or regulatory agency or court preventing the sale of securities under such registration
statement for any reason (other than a violation of applicable law solely by any Selling Holder and has not thereafter become effective) or 
 (iii) if, in the case of an underwritten offering, the conditions to closing specified in an underwriting agreement to which the Company is a party are not satisfied or waived other than by reason of any
breach or failure by any Selling Holder. 
 The Selling Holders to be included in a registration statement pursuant to
Section 2(a) may at any time terminate such request for registration in accordance with Section 2(a)(ii)(D); provided, that, for the avoidance of doubt, the Company shall have been deemed to have effected such registration restatement for
the purposes of this Section 2(a). 
 (e) Selection of Underwriters. The underwriter or underwriters of each
underwritten offering, if any, of the Registrable Common Stock to be registered pursuant to Section 2(a) hereof shall be mutually selected by the Selling Holders beneficially owning at least a majority of the shares of Registrable Common Stock
to be registered and the Company. In the case of any offering or registration initiated by the Company for its own account or any other offering not effected pursuant to Section 2(a) or 2(i) hereof, including any offering pursuant to which the
Holders shall have piggyback rights pursuant to Section 3 hereof, the Company shall select a nationally recognized underwriter (or underwriters) for such offering in its sole discretion; provided that, the Company shall not identify any
Holder or subsequent purchaser of Registrable Common Stock as an underwriter in any public disclosure with the Commission or any trading market without the prior written consent of such Holder or such subsequent purchaser, as the case may be, unless
required by law. If the Company is required by law to identify any such party as an underwriter in any public disclosure or filing with the Commission or any trading market, it must notify such party in advance and such party shall have the option,
in its sole discretion, to consent to such identification as an underwriter within five (5) Business Days or such party shall be deemed to have consented to have its Registrable Common Stock removed from the applicable registration statement.

  
 6 

 (f) Priority in Requested Registration. If a registration requested pursuant to
Section 2(a) hereof involves an underwritten Public Offering, and the managing underwriter of such underwritten offering shall advise the Company in writing (with a copy to each Selling Holder requesting that Registrable Common Stock be
included in such registration statement) that, in its opinion, the number of shares of Registrable Common Stock requested to be included in such registration exceeds the number of such securities that can be sold in such offering within a price
range stated to such managing underwriter by Selling Holders beneficially owning at least a majority of the shares of Registrable Common Stock requested to be included in such registration to be acceptable to such Selling Holders (such writing to
state the basis of such opinion and the approximate number of securities which the managing underwriter believes may be included in such offering without such effect), then the Company shall include in such registration, to the extent of the number
of shares which the Company is so advised the managing underwriter believes can be sold in such offering, (i) first, all Registrable Common Stock requested to be registered pursuant to Section 2(a) pro rata among the Selling
Holders on the basis of the number of shares of Registrable Common Stock requested to be registered by all such Selling Holders, (ii) second, securities that the Company proposed to issue and sell for its own account and (iii) third, other
securities, if any. 
 (g) Shelf Registrations. If one or more demands made pursuant to Section 2(a) hereof are for
a Shelf Registration or any demands are made pursuant to Section 2(i) hereof, the period for which the Shelf Registration Statement in connection with the first Shelf Registration requested pursuant to Section 2(a) or 2(i) must remain
effective need not extend beyond one (1) year from the date on which such Shelf Registration Statement initially was declared effective by the Commission and the period for which any subsequent Shelf Registration Statement in connection with
the subsequent Shelf Registration requested pursuant to Section 2(a) or 2(i) must remain effective need not extend beyond nine (9) months from the date on which such Shelf Registration Statement initially was declared effective by the
Commission (plus, in each case, a number of Business Days equal to the number of Business Days, if any, that the Shelf Registration Statement is not kept effective (including any days for which the use of the prospectus is suspended pursuant to
Section 8(b)) after the initial date of its effectiveness and prior to such first-year or nine-month, as the case may be, anniversary thereof). The Company further agrees, if necessary, to supplement or amend the Shelf Registration Statement,
if required by the rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration or by the Securities Act or by any other rules and regulations thereunder for shelf registration, and the
Company agrees to furnish to the Holders whose Registrable Common Stock is included in such Shelf Registration Statement copies of any such supplement or amendment promptly after its being issued or filed with the Commission. Notwithstanding any
other provision in this Agreement, a Holder shall only request a Shelf Registration, and the Company shall only effect a Shelf Registration, if the Company is eligible to file the Shelf Registration Statement on Form S-3 (or a successor form).

 (h) Questionnaire. Notwithstanding any other provision hereof, no Holder’s Registrable Common Stock shall be
included in the Shelf Registration Statement unless and until such Holder furnishes to the Company a fully completed notice and questionnaire substantially in the form attached hereto as Exhibit A (the “Questionnaire”) and such
other information in writing as the Company may reasonably request in writing for use in connection with the Shelf Registration Statement and any related application to be filed with or under state securities laws.

  
 7 

 
As soon as practicable after a request for registration pursuant to Section 2(a), the Company shall provide the Questionnaire to the Holders. In order to be named as a selling stockholder in
the Shelf Registration Statement at the time of effectiveness of the Shelf Registration Statement and to include in the Shelf Registration Statement all Registrable Common Stock requested to be included for sale by the Holder, each Holder must
furnish to the Company in writing the completed Questionnaire and such other information reasonably requested by the Company and the Company will include information contained in the completed Questionnaire and such other information, if any, in the
Shelf Registration Statement, as necessary and in a manner so that upon effectiveness of the Shelf Registration Statement, the Holder will be permitted to deliver the Shelf Registration Statement to purchasers of the Holder’s Registrable Common
Stock. At least thirty (30) days prior to the filing of the Shelf Registration Statement, the Company will provide to the Holders notice of its intention to file the Shelf Registration Statement and such other information the Company may
reasonably request to be provided by the Holders. From and after the date that the Shelf Registration Statement becomes effective, upon receipt of a completed Questionnaire and such other information that the Company may reasonably request in
writing, if any, the Company shall (i) as promptly as practicable after the date on which the Questionnaire is delivered, and in any event within the later of (x) fifteen (15) Business Days after receipt of such Questionnaire or
(y) fifteen (15) Business Days after the expiration of any suspension pursuant to Section 8(b) in effect when the Questionnaire is delivered, file any amendments or supplements to the Shelf Registration Statement necessary for such
Holder to be named as a selling stockholder and to include in the Shelf Registration Statement all Registrable Common Stock requested to be included for sale by such Holder or, if not permitted to name such Holder as a selling stockholder by
supplement, file any necessary post-effective amendment to the Shelf Registration Statement or prepare and, if required by applicable law, file any amendment or supplement to any document so that such Holder is named as a selling stockholder, and
use its commercially reasonable efforts to cause such post-effective amendment to be declared effective as promptly as practicable; provided that the Company shall not be obligated to file more than one (1) post-effective amendment in any
ninety (90) day period. 
 (i) Form S-3 Registration. Any Holder (an “Initiating Form S-3 Holder”)
may request at any time following the Company’s Public Offering that the Company file a registration statement under the Securities Act on Form S-3 (or similar or successor form) covering the sale or other distribution of all or any portion of
the Registrable Common Stock held by such Initiating Form S-3 Holder pursuant to Rule 415 under the Securities Act (“Form S-3 Request”) if (i) the Company is a registrant qualified to use Form S-3 (or any similar or successor
form) to register such Registrable Common Stock and (ii) the plan of distribution of the Registrable Common Stock is other than pursuant to an underwritten public offering. If such conditions are met, the Company shall use its commercially
reasonable efforts to register under the Securities Act on Form S-3 (or any similar or successor form) at the earliest practicable date, for sale in accordance with the method of disposition specified in the Form S-3 Request, the number of
Registrable Common Stock specified in such Form S-3 Request. In connection with a Form S-3 Request, the Company agrees to include in the prospectus included in any registration statement on Form S-3, such material describing the Company and intended
to facilitate the sale of securities being so registered as is reasonably requested for inclusion therein by the Initiating Form S-3 Holders, whether or not the rules applicable to preparation of Form S-3 require the inclusion of such information.
Form S-3 Requests will not be deemed to be Initiating Requests as described in Section 2(a) hereof and Holders shall have the right to request an unlimited 

  
 8 

 
number of Form S-3 Requests. Notwithstanding the foregoing, the Company shall not be obligated to file more than one (1) registration statement on Form S-3 pursuant to this Section 2(i)
in any given six (6) month period. No registration effected under this Section 2(i) shall relieve the Company of its obligation to effect any registration upon request under Section 2(a) hereof and no registration effected
pursuant to this Section 2(i) shall be deemed to have been effected pursuant to Section 2(a) hereof. 

3. Piggyback Registration. If the Company, at any time when a Shelf Registration Statement covering all outstanding shares of
Registrable Common Stock is not effective, proposes to register Common Stock under the Securities Act by registration on any forms (other than Form S-4 or S-8 or any successor or similar form(s)), whether or not pursuant to registration rights
granted to other holders of its securities and whether or not for sale for its own account, it shall give prompt written notice to all of the Holders of its intention to do so and of such Holders’ rights under this Section 3, which notice,
in any event, shall be given at least 21 days prior to such proposed registration. Upon the written request of any Holder receiving notice of such proposed registration (each, a “Piggyback Requesting Holder”) made within 15 days
after the receipt of any such notice (or 5 days if the Company states in such written notice or gives telephonic notice to the Holders, with written confirmation to follow promptly thereafter, stating that (i) such registration will be on Form
S-3 (or, if Form S-3 is not then available to the Company, Form S-1 or any other appropriate form) and (ii) such shorter period of time is required because of a planned filing date), which request shall specify the Registrable Common Stock
intended to be disposed of by such Piggyback Requesting Holder and the minimum offering price per share at which such Piggyback Requesting Holder is willing to sell its Registrable Common Stock, the Company shall, subject to Section 6(b)
hereof, effect the registration under the Securities Act of all Registrable Common Stock which the Company has been so requested to register by the Piggyback Requesting Holders thereof; provided that, 

(A) prior to the effective date of the registration statement filed in connection with such registration or, in the case
of a Shelf Registration Statement, prior to the delivery of a preliminary prospectus related to such offering, and, in any event, promptly following receipt of notification by the Company from the managing underwriter (if an underwritten offering)
of a range of prices at which such securities are likely to be sold, the Company shall so advise each Piggyback Requesting Holder of such price, and if such price is below the minimum price which shall be acceptable to such Piggyback Requesting
Holder, such Piggyback Requesting Holder shall then have the right irrevocably to withdraw its request to have its Registrable Common Stock included in such registration statement, by delivery of written notice of such withdrawal to the Company
within three (3) Business Days of its being advised of such price, without prejudice to the rights of any such Piggyback Requesting Holder to include Registrable Common Stock in any future registration (or registrations) pursuant to this
Section 3 or to cause such registration to be effected as a registration under Section 2(a) or 2(i) hereof, as the case may be; 
 (B) if at any time after giving written notice of its intention to register the offer for sale of any securities and prior to the effective date of the registration statement filed in connection with such
registration or, in the case of a 

  
 9 

 
Shelf Registration Statement, prior to the consummation of such offering, the Company shall determine for any reason not to register or to delay registration of such securities, the Company may,
at its election, give written notice of such determination to each Piggyback Requesting Holder and (i) in the case of a determination not to register, the Company shall be relieved of its obligation to register any Registrable Common Stock in
connection with such registration (but not from any obligation of the Company to pay the Expenses in connection therewith), without prejudice, however, to the rights of any Piggyback Requesting Holder to include Registrable Common Stock in any
future registration (or registrations) pursuant to this Section 3 or, if applicable, to cause such registration to be effected as a registration under Section 2(a) or 2(i) hereof, as the case may be, and (ii) in the case of a
determination to delay registering, shall be permitted to delay registering any Registrable Common Stock, for the same period as the delay in registering such other securities; and 

(C) if such registration was initiated by the Company for its own account and involves an underwritten offering, each
Piggyback Requesting Holder shall sell its Registrable Common Stock on the same terms and conditions as those that apply to the Company, and the underwriters of each such underwritten offering shall be a nationally recognized underwriter (or
underwriters) selected by the Company in its sole discretion. 
 No registration effected under this Section 3 shall
relieve the Company of its obligation to effect any registration upon request under Section 2(a) or 2(i) hereof and no registration effected pursuant to this Section 3 shall be deemed to have been effected pursuant to Section 2(a) or
2(i) hereof. 
 4. Expenses. Except as provided in the last paragraph of Section 5, the Company shall pay all
Expenses in connection with any registration initiated pursuant to Sections 2(a), 2(i) or 3 hereof, whether or not such registration shall become effective and whether or not all or any portion of the Registrable Common Stock originally requested to
be included in such registration are ultimately included in such registration. 
 5. Registration Procedures. If and
whenever the Company is required to effect any registration under the Securities Act as provided in Sections 2(a), 2(i) and 3 hereof, the Company shall, as expeditiously as practicable: 

(a) prepare and file with the Commission (promptly and, in the case of any registration pursuant to Section 2(a) or
2(i), in any event on or before the date that is (i) 90 days after the date of any Initiating Request or the Form S-3 Request or (ii) if, as of such ninetieth day, the Company does not have the audited financial statements required to be
included in the registration statement, 30 days after the receipt by the Company from its independent public accountants of such audited financial statements, which the Company shall use its reasonable commercially reasonable efforts to obtain as
promptly as practicable) the requisite registration statement to effect such registration and thereafter use its commercially reasonable efforts to cause such registration statement to become and remain effective; provided, however,
that the Company may discontinue any 

  
 10 

 
registration of its securities that are not shares of Registrable Common Stock (and, pursuant to, and under the circumstances specified in, Sections 3 and 8(b) hereof, its securities that are
shares of Registrable Common Stock) at any time prior to the effective date of the registration statement relating thereto; 
 (b) prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration
statement effective and to comply with the provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Common Stock covered by such registration statement until such time as all of such Registrable Common
Stock has been disposed of in accordance with the method of disposition set forth in such registration statement; provided, that, except with respect to any Shelf Registration, such period need not extend beyond 90 days after the
effective date of the registration statement (plus a number of Business Days equal to the number of Business Days, if any, that the registration statement is not kept effective (including any days for which the use of the prospectus is suspended
pursuant to Section 8(b)) after the initial date of its effectiveness and prior to the expiration of such 90-day period); and provided, further, that with respect to any Shelf Registration, such period need not exceed the
applicable period provided for in Section 2(g) hereof; 
 (c) furnish to each seller of Registrable Common
Stock covered by such registration statement and their representatives designated pursuant to Section 7(a), if any, and each underwriter, if any, such number of copies of such drafts and final conformed versions of such registration statement
and of each such amendment and supplement thereto (in each case including all exhibits and any documents incorporated by reference), such number of copies of such drafts and final versions of the prospectus contained in such registration statement
(including each preliminary prospectus and any summary prospectus) and any other prospectus filed under Rule 424 under the Securities Act, in conformity with the requirements of the Securities Act, and such other documents, including without
limitation notification of whether such registration statement or amendment or supplement thereto will be reviewed by the Commission or any other regulatory authority, as the sellers beneficially owning at least a majority of the shares of
Registrable Common Stock covered by such registration statement or any underwriter may reasonably request in writing; provided, that all drafts of such registration statement or amendment or supplement thereto shall be furnished to each
seller of Registrable Common Stock covered by such registration statement and their representatives designated pursuant to Section 7(a) whether or not so requested; 

(d) use its commercially reasonable efforts (i) to register or qualify all Registrable Common Stock and other
securities, if any, covered by such registration statement under such other securities or blue sky laws of such states or other jurisdictions of the United States of America as the Selling Holders covered by such registration statement shall
reasonably request in writing, (ii) to keep such registration or qualification in effect for so long as such registration statement remains in effect and (iii) to take any other action that may be necessary or reasonably advisable to
enable such sellers to consummate the disposition in such jurisdictions of the securities to be sold by such sellers, except that the Company shall not for any such purpose be required to 

  
 11 

 
qualify generally to do business as a foreign corporation in any jurisdiction wherein it would not but for the requirements of this subsection (d) be obligated to be so qualified, to subject
itself to taxation in such jurisdiction or to consent to general service of process in any such jurisdiction; 

(e) use its commercially reasonable efforts to cause all Registrable Common Stock covered by such registration statement
to be registered with or approved by such other federal or state governmental agencies or authorities as may be necessary upon the advice of counsel to the Company or counsel to the seller of Registrable Common Stock or Selling Holders to enable the
seller or sellers thereof to consummate the disposition of such Registrable Common Stock; 
 (f) use its
commercially reasonable efforts to obtain and, if obtained, furnish to each such seller’s underwriters, if any, a signed 
 (i) opinion of counsel for the Company, dated the effective date of such registration statement (and, if such registration involves an underwritten offering, dated the date of the closing under the
underwriting agreement and addressed to the underwriters), in the then-current customary form and covering such matters of the type customarily covered from time to time by legal opinions of such nature, and 

(ii) “cold comfort” letter, dated the effective date of such registration statement (and, if such registration
involves an underwritten offering, dated the date of the closing under the underwriting agreement and addressed to the underwriters) and signed by the independent public accountants who have certified the Company’s financial statements included
or incorporated by reference in such registration statement, reasonably satisfactory (based on the customary form and substance of “cold comfort” letters of issuers’ independent public accountant customarily given in such an offering)
in form and substance to such seller, in each case, covering substantially the same matters with respect to such registration statement (and the prospectus included therein) and, in the case of the accountants’ comfort letter, with respect to
events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer’s counsel and in accountants’ comfort letters delivered to underwriters in such types of offerings of securities; 

(g) notify each seller of Registrable Common Stock and other securities covered by such registration statement, if any, at
any time when a prospectus relating thereto is required to be delivered under the Securities Act, upon discovery that, or upon the happening of any event as a result of which, the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they were made and for
which the Company chooses to suspend the use of the registration statement and prospectus pursuant to Section 8(b), and, in accordance with Section 8(b), at the written request of any such seller of Registrable Common Stock, promptly
prepare and furnish to it a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such 

  
 12 

 
securities, such prospectus, as supplemented or amended, shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading in the light of the circumstances under which they were made; 
 (h)
use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of a registration statement relating to the Registrable Common Stock at the earliest possible moment; 

(i) otherwise comply with all applicable rules and regulations of the Commission and any other governmental agency or
authority having jurisdiction over the offering, and make available to its stockholders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve months, but not more than eighteen months, beginning with the
first full calendar month after the effective date of such registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 promulgated thereunder, and furnish to each seller of
Registrable Common Stock and to the managing underwriter, if any, at least ten days prior to the filing thereof (or such shorter time period reasonably necessary in light of applicable legal requirements) a copy of any amendment or supplement to
such registration statement or prospectus; 
 (j) use its commercially reasonable efforts to cause all
Registrable Common Stock covered by a registration statement (i) to be listed on a national securities exchange on which similar securities issued by the Company are then listed, if the listing of such Registrable Common Stock is then permitted
under the rules of such exchange, or (ii) if the Company is not required pursuant to clause (i) above to list Registrable Common Stock on a specific national securities exchange, use its commercially reasonable efforts to list the
Registrable Common Stock on a national securities exchange and, without limiting the generality of the foregoing, use its commercially reasonable efforts to arrange for at least two market makers to register with FINRA as such with respect to such
Registrable Common Stock; 
 (k) provide a transfer agent and registrar for the Registrable Common Stock covered
by a registration statement no later than the effective date thereof; 
 (l) enter into such agreements
(including an underwriting agreement in customary form) and take such other actions as the Selling Holders beneficially owning at least a majority of the shares of Registrable Common Stock covered by such registration statement shall reasonably
request in order to expedite or facilitate the disposition of such Registrable Common Stock, including customary indemnification; 
 (m) if requested by the managing underwriter(s) or the Selling Holders beneficially owning at least a majority of the shares of Registrable Common Stock being sold in connection with an underwritten
offering, promptly incorporate in a prospectus supplement or post-effective amendment such information provided to the Company in writing as the managing underwriter(s) and the Selling Holders beneficially owning at least a majority of the
Registrable Common Stock being sold agree should be included 

  
 13 

 
therein relating to the plan of distribution with respect to such Registrable Common Stock, including without limitation, information with respect to the number of shares of Registrable Common
Stock being sold to such underwriters, the purchase price being paid therefor by such underwriters and with respect to any other terms of the underwritten offering of the Registrable Common Stock to be sold in such offering, and make all required
filings of such prospectus supplement or post-effective amendment as soon as notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and 

(n) cooperate with the Selling Holders and the managing underwriter(s), if any, to facilitate the timely preparation and
delivery of certificates representing Registrable Common Stock to be sold and not bearing any restrictive legends, and enable such Registrable Common Stock to be in such share amounts and registered in such names as the managing underwriter(s) or,
if none, the Selling Holders beneficially owning at least a majority of the shares of Registrable Common Stock being offered for sale, may request at least three Business Days prior to any sale of Registrable Common Stock to the underwriters.

 As a condition to the obligations of the Company to complete any registration pursuant to this Agreement with respect to the
Registrable Common Stock of a Selling Holder, such Selling Holder must furnish to the Company in writing such information regarding itself, the Registrable Common Stock held by it and the intended methods of disposition of the Registrable Common
Stock held by it as is necessary to effect the registration of such Selling Holders’ Registrable Common Stock and is requested in writing by the Company. Except as otherwise required by Section 2(h), at least thirty days prior to the first
anticipated filing date of a registration statement for any registration under this Agreement, the Company will notify in writing each Holder of the information referred to in the preceding sentence which the Company is requesting from such Holder
whether or not such Holder has elected to have any of its Registrable Common Stock included in the registration statement. If, within ten days prior to the anticipated filing date, the Company has not received the requested information from such
Holder, then the Company may file the registration statement without including Registrable Common Stock of such Holder if, in the opinion of the Company’s counsel, such information is required to be included in such registration statement.

 Each Holder agrees that as of the date that a final prospectus is made available to it for distribution to prospective
purchasers of Registrable Common Stock it shall cease to distribute copies of any preliminary prospectus prepared in connection with the offer and sale of such Registrable Common Stock. Each Holder further agrees that, upon receipt of any notice
from the Company of the happening of any event of the kind described in Section 5(g) and a suspension of the use of the registration statement and prospectus pursuant to Section 8(b), such Holder shall forthwith discontinue such
Holder’s disposition of Registrable Common Stock pursuant to the registration statement and prospectus relating to such Registrable Common Stock until such Holder’s receipt of the copies of the supplemented or amended prospectus
contemplated by Section 5(g) and, if so directed by the Company, shall deliver to the Company (at the Company’s expense) all copies, other than permanent file copies, then in such Holder’s possession of the prospectus relating to such
Registrable Common Stock at the time of receipt of such notice. If any event of the kind described in Section 5(g) occurs and such event is the fault solely of a Holder (or Holders), such Holder (or Holders) shall pay all Expenses attributable
to the preparation, filing and delivery of any supplemented or amended prospectus contemplated by Section 5(g). 

  
 14 

 6. Underwritten Offerings. 

(a) Requested Underwritten Offerings. If requested by the underwriters in connection with a request for a registration (that is not
a Shelf Registration) under Section 2(a) hereof or any underwritten “takedown” of securities under a Shelf Registration Statement filed pursuant to Section 2(a), the Company shall enter into a firm commitment underwriting
agreement with such underwriters for such offering, such agreement to be reasonably satisfactory in substance and form to the Company, a majority of the Selling Holders whose Registrable Common Stock is to be included in such registration and the
underwriters and to contain such representations and warranties by the Company and the Selling Holders and such other terms as are customary in agreements of that type, including, without limitation, indemnification and contribution to the effect
and to the extent provided in Section 9 hereof. 
 (b) Piggyback Underwritten Offerings: Priority. 

(i) If the Company proposes to register any of its securities under the Securities Act for its own account as contemplated
by Section 3 hereof and such securities are to be distributed by or through one or more underwriters, and if the managing underwriter of such underwritten offering shall advise the Company in writing (with a copy to the Piggyback Requesting
Holders) that if all the Registrable Common Stock requested to be included in such registration were so included, in its opinion, the number and type of securities proposed to be included in such registration would exceed the number and type of
securities which the managing underwriter believes could be sold in such offering within a price range acceptable to the Company (such writing to state the basis of such opinion and the approximate number and type of securities which the managing
underwriter believes may be included in such offering without such effect), then the Company shall include in such registration pursuant to Section 3, to the extent of the number of securities which the Company is so advised the managing
underwriter believes can be sold in such offering, (i) first, securities that the Company proposes to issue and sell for its own account, (ii) second, Registrable Common Stock requested to be registered by Piggyback Requesting Holders
pursuant to Section 3 hereof, pro rata among the Piggyback Requesting Holders on the basis of the number of shares of Registrable Common Stock requested to be registered by all such Piggyback Requesting Holders, if any, and
(iii) third, other securities, if any. 
 (ii) In the case of any other registration contemplated by
Section 3 involving an underwritten Public Offering, if the managing underwriter of such underwritten offering shall advise the Company in writing (with a copy to the Piggyback Requesting Holders) that if all Registrable Common Stock requested
to be included in such registration were so included, in its opinion, the number and type of securities proposed to be included in such registration would exceed the number and type of securities which the managing underwriter believes could be sold
in such offering within a price range stated to such managing underwriter by Selling Holders beneficially owning 

  
 15 

 
at least a majority of the shares of Registrable Common Stock requested to be included in such registration to be acceptable to such Selling Holders (such writing to state the basis of such
opinion and the approximate number and type of securities which the managing underwriter believes may be included in such offering without such effect), then the Company shall include in such registration pursuant to Section 3, to the extent of
the number of securities which the Company is so advised the managing underwriter believes can be sold in such offering, (i) first, Registrable Common Stock requested to be registered by Piggyback Requesting Holders pursuant to Section 3
hereof, pro rata among the Piggyback Requesting Holders on the basis of the number of shares of Registrable Common Stock requested to be registered by all such Piggyback Requesting Holders, (ii) second, securities that the Company
proposed to issue and sell for its own account and (iii) third, other securities, if any. 
 Any Selling Holder may
withdraw its request to have all or any portion of its Registrable Common Stock included in any such offering by notice to the Company within 10 Business Days after receipt of a copy of a notice from the managing underwriter pursuant to this
Section 6(b). 
 (c) Selling Holders to be Parties to Underwriting Agreement. Each Selling Holder whose Registrable
Common Stock is to be distributed by underwriters in an underwritten offering contemplated by subsections (a) or (b) of this Section 6 shall be a party to the underwriting agreement between the Company, such underwriters and any such
Selling Holder and, at its option, may reasonably require that any or all of the representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such underwriters shall also be made to and for the
benefit of such Selling Holder (except to the extent any such provision contradicts the terms of this Agreement) and that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement be conditions
precedent to the obligations of such Selling Holder. No such Selling Holder shall be required to make any representations or warranties to or agreements with the Company or the underwriters other than representations, warranties or agreements
regarding such Selling Holder, such Selling Holder’s Registrable Common Stock and such Selling Holder’s intended method of distribution. 
 (d) Holdback Agreements. Each Holder agrees, unless otherwise agreed to by the managing underwriter for any underwritten offering pursuant to this Agreement, not to effect any sale or distribution
of any equity securities of the Company or securities convertible into or exchangeable or exercisable for equity securities of the Company, including any sale under Rule 144 under the Securities Act, during the 10 days prior to the date on which an
underwritten registration of Registrable Common Stock pursuant to Section 2 or 3 hereof has become effective and until the earlier of (a) the date on which all Registrable Common Stock to be sold pursuant to such underwritten registration
has been sold by the underwriters and (b) 90 days after the effective date of such underwritten registration or such shorter period of time acceptable to the managing underwriter of such underwritten offering, if any, except as part of such
underwritten registration or to the extent that such Holder is prohibited by applicable law from agreeing to withhold securities from sale or is acting in its capacity as a fiduciary or an investment adviser. Without limiting the scope of the term
“fiduciary,” a Holder shall be deemed to be acting as a fiduciary or an investment adviser if its actions or the securities proposed to be sold are subject to the Employee Retirement Income Security Act of 1974, as amended, the Investment
Company Act of 1940, as amended, or the Investment Advisers Act of 1940, as amended, or if such securities are held in a separate account under applicable insurance law or regulation. 

  
 16 

 The Company agrees (i) not to effect any sale or distribution of any equity securities
of the Company, or securities convertible into or exchangeable or exercisable for equity securities of the Company (except pursuant to registrations on Form S-4 or Form S-8 or any successor thereto), during the 10 days prior to the date on which an
underwritten registration of Registrable Common Stock pursuant to Section 2 or 3 hereof has become effective and until the earlier of (a) the date on which all Registrable Common Stock to be sold pursuant to such underwritten registration
has been sold by the underwriters and (b) 90 days after the effective date of such underwritten registration or such shorter period of time approved in writing by the managing underwriter of such underwritten offering, if any, except as part of
such underwritten registration, and (ii) to cause each holder of any equity securities, or securities convertible into or exchangeable or exercisable for equity securities, in each case, acquired from the Company at any time on or after the
date of this Agreement (other than in a Public Offering or sale under Rule 144 promulgated under the Securities Act), who is a director or employee of or a consultant to the Company or who has received registration rights from the Company, to agree
not to effect any sale or distribution of such securities during the applicable period (or such shorter period of time approved in writing by the managing underwriter of such underwritten offering, if any). 

7. Preparation: Reasonable Investigation. 
 (a) Registration Statements. In connection with the preparation and filing of each registration statement under the Securities Act pursuant to this Agreement, the Company shall (i) give
representatives (designated to the Company in writing) of each Selling Holder or group of Selling Holders, the underwriters, if any, and one firm of counsel, one firm of accountants and one firm of other agents retained on behalf of all underwriters
and one firm of counsel, one firm of accountants and one firm of other agents retained by Selling Holders beneficially owning a majority of the shares of Registrable Common Stock covered by such registration statement on behalf of all Selling
Holders, the reasonable opportunity to participate in the preparation of such registration statement, each prospectus included therein or filed with the Commission, and each amendment thereof or supplement thereto, (ii) upon reasonable advance
notice to the Company, give each of them such reasonable access to all financial and other records, corporate documents and properties of the Company and its Subsidiaries, as shall be necessary, in the reasonable opinion of such Selling
Holders’ and such underwriters’ counsel, to conduct a reasonable due diligence investigation for purposes of the Securities Act, and (iii) upon reasonable advance notice to the Company, provide such reasonable opportunities to discuss
the business of the Company with its officers, directors, employees and the independent public accountants who have certified its financial statements as shall be necessary, in the reasonable opinion of such Selling Holders’ and such
underwriters’ counsel, to conduct a reasonable due diligence investigation for purposes of the Securities Act. 
 (b)
Confidentiality. Each Selling Holder shall maintain the confidentiality of any confidential information received from or otherwise made available by the Company to such Selling Holder in its capacity as such. Information that (i) is or
becomes available to a Selling Holder from a public source other than as a result of a disclosure by such Selling Holder or any of its Affiliates or (ii) is disclosed to a Selling older by a third-party source who the Selling

  
 17 

 
Holder reasonably believes is not bound by an obligation of confidentiality to the Company. Notwithstanding the foregoing, each Selling Holder shall be permitted to disclose confidential
information solely if and only to the extent required to be disclosed by law, government regulation, or court order, provided, however, that such Selling Holder shall use commercially reasonable efforts to promptly provide the Company
with the opportunity to seek confidential treatment of such confidential information. The Selling Holders shall not grant access, and the Company shall not be required to grant access, to information under this Section 7 to any Person who will
not agree to maintain the confidentiality (to the same extent a Selling Holder is required to maintain confidentiality) of any confidential information received from or otherwise made available to it by the Company or the Selling Holders under this
Agreement. 
 8. Postponements. 
 (a) Without limiting any other rights of the Holders under this Agreement, if the Company shall fail to file within the time period specified by this Agreement any registration statement to be filed
pursuant to a request for registration under Section 2(a) or 2(i) hereof, (i) any Selling Holder whose Registrable Common Stock was to be included in such registration shall have the right to withdraw such request and (ii) the Selling
Holders requesting registration shall have the right to withdraw such request to file a registration statement if and only if the Selling Holders that have not elected to withdraw beneficially own, in the aggregate, less than the percentage of
shares of Registrable Common Stock required to initiate a request under Section 2(a), if applicable. Any withdrawal shall be made by giving written notice to the Company within 20 days after the date on which a registration statement would
otherwise have been required to have been filed with the Commission under clause (i) of Section 5(a) hereof (i.e., 20 days after the date that is 90 days after the date of the relevant Initiating Request or Form S-3 Request, or, if, as of
such ninetieth day, the Company does not have the audited financial statements required to be included in the registration statement, 30 days after the receipt by the Company from its independent public accountants of such audited financial
statements). In the event of a withdrawal described in clause (ii) of this Section 8(a), the request for registration shall not be counted for purposes of determining the number of registrations to which the Holders are entitled pursuant
to Section 2(a) hereof. The Company shall pay all Expenses incurred in connection with any withdrawal described in clauses (i) and (ii) of this Section 8(a). 

(b) The Company shall not be obligated to file any registration statement, or file any amendment or supplement to any registration
statement, and may suspend the registration process and/or any Selling Holder’s ability to use a prospectus, at any time (but not to exceed one time in any twelve-month period) when the Company, in the good faith judgment of its Board of
Directors, reasonably believes that (i) the continuation of the registration process thereof at the time requested would adversely affect a pending or proposed material financing or a material acquisition, merger, recapitalization,
consolidation, reorganization or similar transaction, or negotiations, discussions or pending proposals with respect thereto or (ii) the registration statement and any prospectus would, in the Company’s judgment, contain a material
misstatement of fact or omission as a result of an event that has occurred or is continuing. The filing of a registration statement, or any amendment or supplement thereto, by the Company cannot be deferred, and the Selling Holders’ rights to
make sales pursuant to an effective registration statement cannot be suspended, pursuant to the provisions of the preceding sentence, (x) in the case of clause (i) above, for more than ten days after the abandonment or

  
 18 

 
consummation of any of the proposals or transactions set forth in such clause (i), (y) in the case of clause (ii) above, following such time as the Company no longer believes, in its
judgment, that the registration statement and any prospectus would contain a material misstatement of fact or (ii) omission as a result of an event that has occurred or is continuing; provided that the Company will use its commercially
reasonable efforts to update the disclosure in such registration statement and prospectus (whether by amendment or by incorporation by reference) as soon as practicable such that the registration statement and prospectus will not contain a material
misstatement of fact or omission, or (z) in any event, in the case of either clause (i) or clause (ii) above, for more than 120 days after the date of the Board of Directors’ determination; provided that the Company may
not suspend any Selling Holder’s ability to use a prospectus pursuant to this Section 8(b) (including but not limited to as set forth in Section 5(g)) for more than an aggregate of 120 days in any 365-day period. The Company shall
give notice to the Selling Holders that the registration process has been suspended and upon notice duly given pursuant to Section 18(f) hereof, each Selling Holder agrees not to sell any Registrable Common Stock pursuant to any registration
statement until such Selling Holder’s receipt of copies of the supplemented or amended prospectus, or until it is advised in writing by the Company that the prospectus may be used, and has received copies of any additional or supplemental
filings that are incorporated or deemed incorporated by reference in such prospectus. The Company shall not specify the nature of the event giving rise to a suspension in any notice to the Selling Holders of the existence of such a suspension. If
the Company suspends the Selling Holders’ rights to make sales pursuant hereto, the applicable registration period shall be extended by the number of days of such suspension. 

9. Indemnification. 
 (a) Indemnification by the Company. In connection with any registration statement filed by the Company pursuant to Section 2(a), 2(i) or 3 hereof, to the fullest extent permitted by law the
Company shall, and hereby agrees to, indemnify and hold harmless, each Holder and seller of any Registrable Common Stock covered by such registration statement and each other Person who participates as an underwriter in the offering or sale of such
securities and each other Person, if any, who controls (within the meaning of the Exchange Act) such Holder or seller or any such underwriter, and their respective stockholders, directors, officers, employees, partners, agents and Affiliates (each,
a “Company Indemnitee” for purposes of this Section 9(a)), against any losses, claims, damages, liabilities (or actions or proceedings, whether commenced or threatened, in respect thereof and whether or not such indemnified
party is a party thereto), joint or several, and expenses, including, without limitation, the reasonable fees, disbursements and other charges of legal counsel and reasonable costs of investigation, to which such Company Indemnitee may become
subject under the Securities Act or otherwise (collectively, a “Loss” or “Losses”), insofar as such Losses arise out of, are based upon or relate to (i) any breach of any representation or warranty made by the
Company in this Agreement or any other certificate, instrument or document contemplated hereby, (ii) any breach of any covenant, agreement or obligation of the Company contained in this Agreement or any other certificate, instrument or document
contemplated hereby, or (iii) any untrue statement or alleged untrue statement of any material fact contained in any registration statement under which such securities were registered or otherwise offered or sold under the Securities Act or
otherwise, any preliminary prospectus, final prospectus or summary prospectus related thereto, or any amendment or supplement thereto (or in any document incorporated by reference in any of the foregoing) (collectively, “Offering 

  
 19 

 
Documents”), or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein in the light of the
circumstances in which they were made not misleading or any violation by the Company of any federal or state law, rule or regulation applicable to the Company and relating to action required of or inaction by the Company in connection with any such
registration; provided that, the Company shall not be liable to any Company Indemnitee in any such case to the extent that any such Loss arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged
omission made in such Offering Documents in reliance upon and in conformity with information furnished to the Company in a writing by such Company Indemnitee specifically stating that it is expressly for use therein. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of such Company Indemnitee and shall survive the transfer of such securities by such Company Indemnitee. 

(b) Indemnification by the Offerors and Sellers. In connection with any registration statement filed by the Company pursuant to
Section 2(a), 2(i) or 3 hereof in which a Selling Holder has registered for sale Registrable Common Stock, each such Selling Holder or seller of Registrable Common Stock shall, and hereby agrees to, on a several and not joint basis, indemnify
and hold harmless to the fullest extent permitted by law the Company and each of its directors, officers, employees, agents, partners, stockholders, Affiliates and each other Person, if any, who controls (within the meaning of the Exchange Act) the
Company and each other seller and such seller’s employees, directors, officers, stockholders, partners, agents and Affiliates (each, a “Holder Indemnitee” for purposes of this Section 9(b)), against all Losses insofar as
such Losses arise out of, are based upon or relate to any untrue statement or alleged untrue statement of a material fact contained in any Offering Documents or any omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein in the light of circumstances in which they were made not misleading, but only to the extent that such untrue statement or alleged untrue statement or omission or alleged omission was made in
reliance upon and in conformity with information furnished to the Company in a writing duly executed by such Selling Holder or seller of Registrable Common Stock expressly for use therein; provided, however, that the liability of such
indemnifying party under this Section 9(b) shall be limited to the amount of the net proceeds received by such indemnifying party in the sale of Registrable Common Stock giving rise to such liability. Such indemnity shall remain in full force
and effect, regardless of any investigation made by or on behalf of the Selling Holder Indemnitee and shall survive the transfer of such securities by such indemnifying party. 
 (c) Notices of Losses, etc. Promptly after receipt by an indemnified party of written notice of the commencement of any action or proceeding involving a Loss referred to in the preceding
subsections of this Section 9, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party, give written notice to the latter of the commencement of such action; provided, however, that
the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations under the preceding subsections of this Section 9, except to the extent that the indemnifying party is materially
and actually prejudiced by such failure to give notice. In case any such action is brought against an indemnified party, the indemnifying party shall be entitled to participate in and, unless in such indemnified party’s reasonable judgment a
conflict of interest between such indemnified and indemnifying parties may exist in respect of such Loss, to assume and control 

  
 20 

 
the defense thereof, in each case at its own expense, jointly with any other indemnifying party similarly notified, to the extent that it may wish, with counsel reasonably satisfactory to such
indemnified party, and after its assumption of the defense thereof, the indemnifying party shall not be liable to such indemnified party for any legal or other expenses subsequently incurred by the latter in connection with the defense thereof other
than reasonable costs of investigation, unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties arises in respect of such claim after the assumption of the defense thereof.
No indemnifying party shall be liable for any settlement of any such action or proceeding effected without its written consent, which shall not be unreasonably withheld. No indemnifying party shall, without the consent of the indemnified party,
consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such Loss or which
requires action on the part of such indemnified party or otherwise subjects the indemnified party to any obligation or restriction to which it would not otherwise be subject. 
 (d) Contribution. If the indemnification provided for in this Section 9 shall for any reason be unavailable to an indemnified party under subsection (a) or (b) of this Section 9
in respect of any Loss, then, in lieu of the amount paid or payable under subsection (a) or (b) of this Section 9, the indemnified party and the indemnifying party under subsection (a) or (b) of this Section 9 shall
contribute to the aggregate Losses (including legal or other expenses reasonably incurred in connection with investigating the same) (i) in such proportion as is appropriate to reflect the relative fault of the Company and the prospective
Selling Holders covered by the registration statement which resulted in such Loss or action in respect thereof, with respect to the statements, omissions or action which resulted in such Loss or action in respect thereof, as well as any other
relevant equitable considerations, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one
hand, and such prospective sellers, on the other hand, from their sale of Registrable Common Stock; provided that, for purposes of this clause (ii), the relative benefits received by the prospective sellers shall be deemed not to exceed the
net proceeds received by such sellers. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. The obligations, if any, of the Selling Holders to contribute as provided in this subsection (d) are several in proportion to the relative value of their respective Registrable Common Stock covered by such registration
statement and not joint. In addition, no Person shall be obligated to contribute hereunder any amounts in payment for any settlement of any action or Loss effected without such Person’s consent, which shall not be unreasonably withheld.

 (e) Indemnification Payments. The indemnification and contribution required by this Section 9 shall be made by
periodic payments of the amount thereof during the course of any investigation or defense, as and when any Loss is incurred and is due and payable. 
 10. Registration Rights to Others. 
 If the Company shall at any time
hereafter provide to any holder of any securities of the Company rights with respect to the registration of such securities under the Securities Act or the Exchange Act, such rights shall not be in conflict with or adversely affect any of the rights
provided to the Holders in, or conflict (in a manner that adversely affects the Holders) with any other provisions included in, this Agreement. 

  
 21 

 11. Adjustments Affecting Registrable Common Stock. 

Without the written consent of the Holders beneficially owning a majority of the outstanding shares of Registrable Common Stock, the
Company shall not effect or permit to occur any combination, subdivision or reclassification of Registrable Common Stock that would materially adversely affect the ability of the Holders to include such Registrable Common Stock in any registration
of its securities under the Securities Act contemplated by this Agreement or the marketability of such Registrable Common Stock under any such registration or other offering. 
 12. Rule 144 and Rule 144A; Listing. 
 If the Company has a class of
equity securities registered under the Exchange Act, the Company shall take all actions reasonably necessary to: 
 (a) enable
the Holders to sell Registrable Common Stock without registration under the Securities Act to the maximum extent permitted by the exemptions provided by (i) Rule 144 under the Securities Act, as such Rule may be amended from time to time,
(ii) Rule 144A under the Securities Act, as such Rule may be amended from time to time, or (iii) any similar rules or regulations hereafter adopted by the Commission, including, without limiting the generality of the foregoing, filing on a
timely basis all reports required to be filed under the Exchange Act. Upon the written request of any Holder, the Company shall deliver to such Holder a written statement as to whether it has complied with such requirements; and 

(b) cause the Common Stock to be listed or qualified for trading on a national securities exchange in the United States on or as soon as
reasonably practicable following the Effective Date. 
 13. Amendments and Waivers. 

Any provision of this Agreement may be amended, modified or waived if, but only if, the written consent to such amendment, modification or
waiver has been obtained from the Company and (i) except as provided in clauses (ii) and (iii) below, from the Holders of at least two-thirds of the shares of Registrable Common Stock affected by such amendment, modification or
waiver, (ii) in the case of any amendment, modification or waiver of any provision of Section 4, 8 or 9 hereof or this Section 13 or any provisions as to the number of requests for registration to which Holders are entitled under
Section 2 or 3 hereof, from each Holder, and (iii) in the case of any other amendment, modification or waiver of any provision of this Agreement which adversely affects any right and/or obligation under this Agreement of any Holder, from
each Holder so affected. Notwithstanding the foregoing, the Company may from time to time add additional Holders as parties to this Agreement. In order to become a party to this Agreement, such additional party must execute a joinder agreement, in
form and substance satisfactory to the Company, evidencing such party’s agreement to be bound hereby as a Holder, and upon the Company’s receipt of any such additional Holder’s executed joinder agreement, such additional Holder shall
be deemed to be a party hereto and bound hereby. 

  
 22 

 14. Nominees for Beneficial Owners. 

In the event that any Registrable Common Stock is held by a nominee for the beneficial owner thereof, the beneficial owner thereof may, at
its election in writing delivered to the Company, be treated as the holder of such Registrable Common Stock for purposes of any request or other action by any Holder or Holders pursuant to this Agreement or any determination of the number or
percentage of shares of Registrable Common Stock held by any Holder or Holders contemplated by this Agreement. If the beneficial owner of any Registrable Common Stock so elects, the Company may require assurances reasonably satisfactory to it of
such owner’s beneficial ownership of such Registrable Common Stock. 
 15. Assignment. 

The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs,
successors and permitted assigns. Any Holder may Transfer to any permitted Transferee (as permitted under applicable law) its Registrable Common Stock and its rights and obligations under this Agreement, provided that such Transferee shall
agree in writing prior to the assignment to be bound by this Agreement as if it were an original party hereto, whereupon such Transferee shall for all purposes be deemed to be a Holder under this Agreement but only if, in the event such Transferee
is not one of the initial signatories to this Agreement or any of their respective Affiliates, (i) such Transferee beneficially owns at least two percent (2%) of the then outstanding shares of Registrable Common Stock after giving effect
to such Transfer or (ii) the Transferor Transfers to such Transferee at least two percent (2%) of the shares of Registrable Common Stock outstanding as of the date of this Agreement. Except as provided above or otherwise permitted by this
Agreement, neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by any Holder without the prior written consent of the other parties hereto. The Company may not assign this
Agreement or any right, remedy, obligation or liability arising hereunder or by reason hereof without the consent of the Holders beneficially owning a majority of the outstanding shares of Registrable Common Stock. 

16. Calculation of Percentage or Number of Shares of Registrable Common Stock. 

For purposes of this Agreement, all references to a percentage or number of shares of Registrable Common Stock or Common Stock shall be
calculated based upon the number of shares of Registrable Common Stock or Common Stock, as the case may be, outstanding at the time such calculation is made (assuming conversion of all outstanding Class B Common Stock into Common Stock) and shall
exclude any Registrable Common Stock or Common Stock, as the case may be, beneficially owned by the Company or any Subsidiary of the Company. For the purposes of calculating any percentage or number of shares of Registrable Common Stock or Common
Stock as contemplated by the previous sentence, the terms “Holder” and “Initiating Holder” shall include all Affiliates thereof (other than the Company and its Subsidiaries) beneficially owning any shares of Registrable Common
Stock or Common Stock. 

  
 23 

 17. Termination of Registration Rights. This Agreement, including, without
limitation, the Company’s obligations under Sections 2(a), 2(i) and 3 hereof to register Common Stock for sale under the Securities Act shall terminate on the earlier of (i) the first date on which there are no Holders that are parties to
this Agreement or (ii) the first date on which all outstanding shares of Registrable Common Stock constitute less than one percent (1%) of the then outstanding shares of Common Stock (assuming conversion of all outstanding Class B Common
Stock into Common Stock). Notwithstanding any termination of this Agreement pursuant to this Section 17, the parties’ obligations under Section 4 and Section 9 hereof shall continue in full force and effect. 

18. Miscellaneous. 
 (a) Further Assurances. The Company shall execute such documents and other papers and perform such further acts as may be reasonably required or advisable to carry out the provisions of this
Agreement and the transactions contemplated hereby. 
 (b) Headings. The headings in this Agreement are for convenience
of reference only and shall not control or affect the meaning or construction of any provisions hereof. 
 (c) Conflicting
Instructions. A Person is deemed to be a holder of Registrable Common Stock whenever such Person owns of record Registrable Common Stock. If the Company receives conflicting instructions, notices or elections from two or more Persons with
respect to the same Registrable Common Stock, the Company will act upon the basis of instructions, notice or election received from the registered owner of such Registrable Common Stock. 

(d) Remedies. Each Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Agreement. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Agreement and the
Company hereby agrees to waive the defense in any action for specific performance that a remedy at law would be adequate. 
 (e)
Entire Agreement. This Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter contained herein, and there are no restrictions, promises, representations, warranties, covenants, or
undertakings with respect to the subject matter hereof, other than those expressly set forth or referred to herein. This Agreement supersedes all prior agreements and understandings between the parties hereto with respect to the subject matter
hereof. 
 (f) Notices. All notices, requests and demands to or upon the respective parties hereto to be effective shall
be in writing (including by telecopy), and, unless otherwise expressly provided herein, shall be deemed to have been duly given or made when delivered by hand, or two Business Days after being delivered to a recognized courier (whose stated terms of
delivery are two Business Days or less to the destination of such notice), or five calendar days after being deposited in the mail, postage prepaid, or, in the case of telecopy notice, when received, addressed as set forth on Schedule A hereto to
the parties hereto, or to such other address as may be hereafter notified by the respective parties hereto. 

  
 24 

 (g) Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware. 
 (h) Severability. Notwithstanding any provision of this Agreement, neither the
Company nor any other party hereto shall be required to take any action which would be in violation of any applicable federal or state securities law. The invalidity or unenforceability of any provision of this Agreement in any jurisdiction shall
not affect the validity, legality or enforceability of any other provision of this Agreement in such jurisdiction or the validity, legality or enforceability of this Agreement, including any such provision, in any other jurisdiction, it being
intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law. 

(i) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of
which shall constitute one and the same Agreement. 
 19. Transfer Agent. The Company shall serve as transfer agent
with respect to transfers of shares of Common Stock until such time as it retains a third party transfer agent to manage such responsibilities. 
 [Remainder of this page intentionally left blank.] 

  
 25 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

			
	SPANSION INC.
		
	By:	 	 /s/ Authorized Signatory

	Name:	 	
	Title:	 	

 HOLDERS: 

 

			
	SLS SPANSION HOLDINGS, LLC
	
	By: SILVER LAKE SUMERU FUND, L.P., its Managing Member
	
	By: SILVER LAKE TECHNOLOGY ASSOCIATES SUMERU, L.P., its General Partner
		
	By:	 	 /s/ Authorized Signatory

	Name:	 	
	Title:	 	

 SCHEDULE A 
 NOTICES 
 If to the Company, to: 
 Spansion Inc. 
 915 DeGuigne Dr. 
 Sunnyvale, CA 94085 
 Attn: General Counsel 

Facsimile: (408) 616-6659 
 with a copy to:

 Latham & Watkins LLP 
 140
Scott Drive 
 Menlo Park, CA 94025 

Attn: Tad J. Freese, Esq. 
 Facsimile:
(650) 463-2600 
 If to the Holders, to: 
 c/o SLS Spansion Holdings, LLC 
 2775 Sand Hill Road 

Suite 100 
 Menlo Park, CA 94025 

Attn: Karen King, Esq. 
 Facsimile:
(650) 234-2502 
 with a copy to: 

Milbank, Tweed, Hadley & McCloy LLP 
 601 South Figueroa Street, 30th Floor 
 Los Angeles, CA 90017 
 Attn: Gregory A. Bray, Esq. 
 and 

Neil J Wertlieb, Esq. 

Facsimile: (213) 629-5063 

 EXHIBIT A 
 FORM OF SELLING STOCKHOLDER QUESTIONNAIRE 
 The undersigned beneficial
owner (the “Selling Stockholder”) of shares (the “Registrable Common Stock”) of common stock, par value $0.01 per share, of Spansion Inc. (the “Company”), hereby gives notice to the Company of its
intention to sell or otherwise dispose of Registrable Common Stock beneficially owned by it and listed below in Item 3 (unless otherwise specified under Item 3) pursuant to the Shelf Registration Statement. The undersigned, by signing and
returning this Selling Stockholder Questionnaire, understands that it will be bound by the terms and conditions of this Selling Stockholder Questionnaire and the Registration Rights Agreement, dated as of May 3, 2010, among the Company and the
Holders named therein (the “Registration Rights Agreement”). Capitalized terms used and not defined herein shall have the meaning ascribed to them in the Registration Rights Agreement. 

In accordance with the Registration Rights Agreement, Selling Stockholders that do not complete this Selling Stockholder Questionnaire
and deliver it to the Company as provided below will not be named selling stockholders in the prospectus and therefore will not be permitted to sell any Registrable Common Stock pursuant to the Shelf Registration Statement. 

Pursuant to the Registration Rights Agreement, the undersigned has agreed to indemnify and hold harmless the Company’s directors,
the Company’s officers and each person, if any, who controls the Company within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act from and against certain losses arising in connection with
statements concerning the undersigned made in the Shelf Registration Statement or the related prospectus in reliance upon the information provided in this Selling Stockholder Questionnaire. The undersigned hereby acknowledges its obligations under
the Registration Rights Agreement to indemnify and hold harmless certain persons set forth therein. 
 Certain legal
consequences arise from being named a selling stockholder in the Shelf Registration Statement and the related prospectus. Accordingly, holders and beneficial owners are advised to consult their own securities law counsel regarding the consequences
of being named or not named as a selling stockholder in the Shelf Registration Statement and the related prospectus. 
 The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate and complete: 
  

					
	(1)	    	(a)	  	 Full Legal Name of Selling Stockholder:

 

			
		    	(b)	  	 Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Common Stock listed in (3) below is
held:
  

			
		    	(c)	  	 Full Legal Name of DTC Participant (if applicable and if not the same as (b) above) through which Registrable Common Stock listed in (3)
below is held:
  

  

  
 A-1

					
	(2)	    	Address for Notices to Selling Stockholder:
		
		    	  

                         
                                         
                                         
                                         
                                 

 

                         
                                         
                                         
                                         
                                 

		    	Telephone (including area
code):                                       
                                         
                                         
                             
		    	Fax (including area
code):                                        
                                         
                                         
                           
		    	Contact
Person:                                        
                                         
                                         
                                       

	(3)	    	Beneficial Ownership of Registrable Common Stock:
		    	  

		    	        (a)	  	Type and Principal Amount/Number of Registrable Common Stock beneficially owned:
		    		  	  

		    	        (b)	  	CUSIP No(s). of such Registrable Common Stock beneficially owned:
		    		  	  

	(4)	    	Beneficial Ownership of Other Securities of the Company Owned by the Selling Stockholder:
		    	Except as set forth below in this Item (4), the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable
Common Stock listed above in Item (3).
		    	        (a)	  	 Type and Amount of Other Securities beneficially owned by the Selling Stockholder:

 

		    	        (b)	  	 CUSIP No(s). of such Other Securities beneficially owned:

 

	(5)	    	Relationship with the Company:
		    	Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (5% or more) has held any position or
office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.
		    	State any exceptions
here:                                        
                                         
                                         
                                       

	(6)	    	Is the Selling Stockholder a registered broker-dealer?
		    	 Yes      ̈

No       ̈
 If “Yes”, please answer subsection (a) and subsection (b):
 (a)      Did the Selling Stockholder acquire the Registrable Common Stock as compensation for underwriting/broker-dealer activities to the Company?

Yes      ̈

No       ̈

(b)      If you answered “No” to question 6(a), please explain your
reason for acquiring the Registrable Common Stock:
  

                      
                                         
                                         
                                         
                                

                      
                                         
                                         
                                         
                                

	(7)	    	 Is the Selling Stockholder an affiliate of a registered broker-dealer?

Yes      ̈
 No       ̈

		    	 If “Yes”, please identify the registered broker-dealer(s), describe the nature of the affiliation(s) and answer
subsection (a) and subsection (b):
  

        
                                         
                                         
                                         
                                      

(a)    Did the Selling Stockholder purchase the Registrable Common Stock in the ordinary
course of business (if no, please explain)?

Yes     
 ̈

  
 A-2

					
	,	    	
No       ̈      
Explain:                                        
                                         

 (b)      Did the Selling Stockholder have an agreement or
understanding, directly or indirectly, with any person to distribute the Registrable Common Stock at the same time the Registrable Common Stock were originally purchased (if yes, please explain)?

Yes      ̈
      Explain:                                 
                                         
       

No       ̈

	(8)	    	Is the Selling Stockholder a non-public entity?
		    	 Yes      ̈

No       ̈
 If “Yes”, please answer subsection (a):

(a)    Identify the natural person or persons that have voting or investment control over the
Registrable Common Stock that the non-public entity owns:
  
                                  
                                         
                                         
                                         
                 

                      
                                         
                                         
                                         
                            

	(9)	    	Plan of Distribution:
		    	Except as set forth below, the undersigned Selling Stockholder (including its donees and pledgees) intends to distribute the Registrable Common Stock listed above
in Item (3) pursuant to the Shelf Registration Statement only as follows (if at all): Such Registrable Common Stock may be sold from time to time directly by the undersigned Selling Stockholder or, alternatively, in accordance with the Registration
Rights Agreement, through underwriters, broker-dealers or agents. If the Registrable Common Stock is sold through underwriters or broker-dealers, the Selling Stockholders will be responsible for underwriting discounts or commissions or agent
commissions. Such Registrable Common Stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of sale, at varying prices determined at the time of sale, or at negotiated prices. Such sales may be
effected in transactions (which may involve cross or block transactions) (i) on any national securities exchange or quotation service on which the Registrable Common Stock may be listed or quoted at the time of sale, (ii) in the
over-the-counter market, (iii) in transactions otherwise than on such exchanges or services or in the over-the-counter market, or (iv) through the writing of options. In connection with sales of the Registrable Common Stock or otherwise,
the undersigned Selling Stockholder may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the Registrable Common Stock in the course of hedging positions they assume. The undersigned Selling Stockholder
may also sell Registrable Common Stock short and deliver Registrable Common Stock to close out short positions, or loan or pledge Registrable Common Stock to broker-dealers that in turn may sell such securities.
		    	State any exceptions
here:                                        
                                         
                    

 The undersigned Selling Stockholder acknowledges that it understands its obligations to comply with
the provisions of the Exchange Act, and the rules thereunder relating to stock manipulation, particularly Regulation M thereunder (or any successor rules or regulations), in connection with any offering of Registrable Common Stock pursuant to
the Shelf Registration Agreement. The undersigned agrees that neither it nor any person acting on its behalf will engage in any transaction in violation of such provisions. 
 Pursuant to the Registration Rights Agreement, the Company has agreed under certain circumstances to indemnify the Selling Stockholder against certain liabilities. 

  
 A-3

 In the event the undersigned transfers all or any portion of the Registrable Common Stock
listed in Item (3) above after the date on which such information is provided to the Company other than pursuant to the Shelf Registration Statement, the undersigned agrees to notify the transferee(s) at the time of the transfer of its rights
and obligations under this Selling Stockholder Questionnaire and the Registration Rights Agreement. 
 In accordance with the
undersigned’s obligation under the Registration Rights Agreement to provide such information as may be required by law or by the staff of the Commission for inclusion in the Shelf Registration Statement, the undersigned agrees to promptly
notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Shelf Registration Statement remains effective. All notices hereunder and pursuant to the
Registration Rights Agreement shall be made in writing, by hand-delivery, first-class mail, or air courier guaranteeing overnight delivery to the address set forth below. 
 By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items (1) through (9) above and the inclusion of such information in the Shelf
Registration Statement and the related prospectus. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Shelf Registration Statement and the related prospectus.

 By signing below, the undersigned agrees that if the Company notifies the undersigned in accordance with and pursuant to the
Registration Rights Agreement that Shelf Registration Statement is not available, the undersigned will in accordance with and pursuant to the Registration Rights Agreement suspend use of the prospectus until notice from the Company that the
prospectus is again available. 
 Once this Selling Stockholder Questionnaire is executed by the undersigned and received by the
Company, the terms of this Selling Stockholder Questionnaire, and the representations, warranties and agreements contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable by the respective successors, heirs,
personal representatives and assigns of the Company and the undersigned with respect to the Registrable Common Stock beneficially owned by the undersigned and listed in Item (3) above. This Selling Stockholder Questionnaire shall be governed in
all respects by the laws of the State of Delaware. 

  
 A-4

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Selling
Stockholder Questionnaire to be executed and delivered either in person or by its duly authorized agent. 
  

							
	Dated:                     	 		 		 	
		 		 	  

		 		 	Beneficial Owner
				
		 		 	By:	 	  

		 		 	Name:	 	  

		 		 	Title:	 	  

 PLEASE RETURN THE COMPLETED AND EXECUTED 

SELLING STOCKHOLDER QUESTIONNAIRE TO THE COMPANY AT: 
 Spansion Inc. 
 915 DeGuigne Dr. 

Sunnyvale, CA 94085 

Attention: General Counsel 
 Facsimile: (408) 616-6659 

  
 A-5Amendment to Co-Promotion Agreement

 Exhibit 10.27 
 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. 
 AMENDMENT TO CO-PROMOTION AGREEMENT 

THIS AMENDMENT TO CO-PROMOTION AGREEMENT (this “Amendment”) is entered into as of the 20th day of December, 2011, by and between Astellas Pharma US, Inc.
(“Astellas”), and Zogenix, Inc. This Amendment amends that certain Co-Promotion Agreement dated as of July 31, 2009 (the “Agreement”), between the Parties (as defined in the Agreement). 

WHEREAS, the Parties desire to amend the Agreement in certain respects, including providing that the Initial Term shall end on
March 31, 2012, all pursuant to the terms and conditions hereof; 
 NOW, THEREFORE, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged by the Parties, the Parties agree as follows: 
 1. Definitions;
Conflict. Unless otherwise defined in this Amendment, the terms and conditions used in this Amendment shall have the meanings ascribed thereto in the Agreement. In the event of any conflict between the terms and conditions of this Amendment and
those set forth in the Agreement, those set forth in the Agreement shall control. 
 2. Zogenix Promotion to Selected
Professionals Within Astellas Segment During 2012 Bridge Period. Notwithstanding anything to the contrary in the Agreement, for the period commencing upon January 1, 2012, and continuing until March 31, 2012 (the “2012 Bridge
Period”), Zogenix shall have the right, subject to applicable Legal Requirements, to Detail the Product to those Professionals in the Astellas Segment within the Territory whose identities are set forth in an exhibit prepared and exchanged by
the Parties as of the date of this Amendment (the “Selected Professionals”). The Parties acknowledge and agree that the lack of Details of the Product to the Selected Professionals by Astellas during the 2012 Bridge Period shall not be a
consideration in whether Astellas has used commercially reasonable efforts to Detail the Product in the Astellas Segment during the 2012 Bridge Period. 
 3. Service Fees During 2012 Bridge Period. With regard to each [***] during the 2012 Bridge Period, the definition of “Astellas Net Sales” in Section 1.16 of the Agreement is
modified by [***] the number of [***] as measured by the third party national audit by Wolters Kluwer (or such other Third Party data source as the Parties may agree from time to time), excluding [***]. 

4. Astellas Promotional Funding Commitment During 2012 Bridge Period; Provision of Remaining Tool Kits. Notwithstanding anything
to the contrary in the Agreement, with regard to the 2012 Bridge Period, the Parties agree that the Base Brand A&P Budget and the Commercial Plan shall not contemplate, provide or require a level of spending by Astellas with respect to A&P
Expenses, and Astellas shall have no obligation [***] in aggregate with respect 
  

	***	Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted
portions. 

  
 1 

 
to A&P Expenses incurred during the 2012 Bridge Period. With regard to the quantity of [***] identified as [***] that are in Astellas’ possession at its [***] on
December 31, 2011, Astellas shall [***]. 
 5. Promotion Transition Plan. The Parties shall use good faith
efforts to agree on a Promotion transition plan no later than February 1, 2012, setting forth a defined process to introduce Zogenix Sales Representatives to mutually agreed Professionals in the Astellas Segment. 

6. JPRC Review of Promotional Material. Notwithstanding anything to the contrary in the Agreement, from the date of this Amendment
until termination of the Agreement, (a) the JPRC shall not be responsible to review or approve any Promotional Material that is solely for use by Zogenix, (b) Zogenix shall have sole responsibility for the review and approval of such
Promotional Materials, and (c) Zogenix shall not use any Astellas Trademark in such Promotional Materials. 
 7. Term
and Termination of Agreement. Sub-Sections 8.2(a)(i) through (v), 8.2(a)(vi)(B), 8.2(a)(vi)(D), 8.2(b), 8.2(c)(ii), 8.2(c)(iii) and 8.4(a) through (d) of the Agreement, and all references in the Agreement to such sub-Sections, are amended
by deleting such sub-Sections and references in their entirety, including the terms and conditions set forth in the Agreement to the extent applicable to each such deleted sub-Sections. Section 8.1 of the Agreement is amended by deleting such
Section in its entirety and substituting the following in lieu thereof: 
 “Section 8.1 Term

 The term of the Agreement shall commence on the Effective Date and shall continue, unless terminated sooner
in accordance with this Article VIII, until March 31, 2012 (the “Initial Term” or the “Term”).” 

8. Termination of Product Agreements. As of the date of the termination of the Agreement, Astellas shall have terminated any and
all agreements entered into by Astellas with third parties to the extent relating to the purpose of the Agreement (the “Product Agreements”). Zogenix shall have no responsibility for any obligations under the Product Agreements from and
after the termination of the Agreement. 
 9. Tail Payments. Section 7.8 of the Agreement is amended by deleting
such Section in its entirety and substituting the following in lieu thereof: 
 “Section 7.8 Tail
Payments 
 Following the Term, Zogenix shall pay Astellas the following payments based on Astellas Net
Sales during the last full twelve (12) months ending March 31, 2012 (such period, the “Final Astellas Promotional Period;” each such payment, a “Tail Payment”): 

 

	***	Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted
portions. 

  
 2 

 (a) On July [***] 2013, an amount equal to [***]
([***]%) of the Astellas Net Sales during the Final Astellas Promotional Period; and 
 (b) On July
[***] 2014, an amount equal to [***] ([***]%) of the Astellas Net Sales during the Final Astellas Promotional Period. 
 In the event the Tail Payment due under (a) above is not received by Astellas on or before the date upon which it is due, the Tail Payment under (b) above shall become immediately due and
payable.” 
 10. Trademark Consent. The Parties acknowledge and agree that, upon termination of the Agreement, the
Trademark Consent dated as of May 10, 2010, between the Parties shall also immediately and automatically terminate. 
 11.
No Claim of Material Breach. Each Party acknowledges that the other Party has not committed a material breach of the Agreement and, in partial consideration of the execution of this Amendment by the other Party, each Party hereby waives and
releases, as of the date of this Amendment, any claim, demand and cause of action, of every nature, that it has or may have against the other Party for any material breach of the Agreement which heretofore has or may have been committed by the other
Party, including, without limitation, any claim for breach of contract, declaratory relief, misrepresentation, or any other form of damage or theory of recovery whatsoever arising out of, based upon or relating to, whether foreseen or unforeseen and
whether known or unknown. The foregoing does not constitute a waiver or release of any material breach of the Agreement that the other Party hereafter may commit, and does not waive, release or limit any right or claim to indemnification that a
Party may have under Article XI of the Agreement or any right or claim that either Party has to receive payments as set forth herein or pursuant to Article VII of the Agreement. 
 The Parties each acknowledge that they have been advised by legal counsel and are familiar with the provisions of California Civil Code Section 1542, which provides as follows: 

“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF
EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.” 
 Each of the Parties
recognizes and understands that such section might apply to and cover the aforementioned claims, demands and/or causes of action, and hereby expressly waives any rights it may have under this section as well as under any other statutes or common law
principles of similar effect. 
 12. No Unapproved Offsets. Except for such offsets as are expressly permitted under
Sections 7.6 and 7.7 of the Agreement, neither Party shall reduce from or offset against any amount due and payable by such Party under the Agreement any payment or amount that is or 
  

	***	Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted
portions. 

  
 3 

 
may be due to such Party under the Agreement or otherwise, without the prior written approval of the other Party; in the absence of such approval, all such payments shall be made when and as due
under the Agreement. 
 13. Survival. The rights and obligations of the Parties arising by virtue of this Amendment shall
survive the termination of the Agreement in accordance with the provisions of Sections 8.4 and 12.4 of the Agreement, including without limitation provisions of the Agreement regarding accounting, reconciliation, reporting and auditing. 

14. Publicity. In regard to the termination of the Agreement on March 31, 2012, neither Party shall issues any
publicity, news release, or other public comment or announcement (including, without limitation, any statements to health care practitioners or customers) without the prior written consent of the other Party, except that no such consent shall be
required to the extent such publicity, release, comment or announcement is, in the opinion of legal counsel to the Party making such disclosure, required by law or the rules or requirements of any stock exchange. Either Party making any such
disclosure required by law or the rules or requirements of any stock exchange shall (unless prohibited by law or the rules or requirements of any stock exchange) give the other Party an opportunity to review and comment upon the form and content of
such disclosure before it is made. Once any such publicity or other statement has been approved by the other Party for disclosure, either Party may make subsequent public disclosures of the content thereof (to the extent the disclosure of such
content remains accurate and not misleading) without the further written approval of the other Party.  
 15.
Further Assurances. Each Party shall undertake such reasonable further acts and execute and deliver such further documents as may be necessary or as the other Party may reasonably require to implement or give effect hereto. 

16. Counterparts. This Amendment may be signed in any number of counterparts, each of which shall be deemed to be an original and
all of which, when taken together, shall have the same effect as if the signatures thereon were on the same instrument. 
 17.
Full Force and Effect. Except as amended hereby, all of the terms and conditions of the Agreement shall remain in full force and effect. 
 IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first above written. 
  

									
	ASTELLAS PHARMA US, INC.	 		 	ZOGENIX, INC.
					
	By:	 	 /s/ M. Yoshida
	 		 	By:	 	 /s/ Roger L. Hawley

		 	Title: President & CEO	 		 		 	Title: CEO
		 	Date: December 20, 2011	 		 		 	Date: Dec. 20, 2011

  
 4 

 December 20, 2011 
 MEMORANDUM OF EXHIBIT 
 Reference is made to that certain Co-Promotion Agreement by
and between Astellas Pharma US, Inc. (“Astellas”) and Zogenix, Inc. (“Zogenix”) dated as of July 31, 2009, as amended by execution of an Amendment (the “Amendment”) on the date hereof (as so amended, the
“Co-Promotion Agreement”). Capitalized terms used but not otherwise defined herein have the meaning set forth in the Co-Promotion Agreement. 
 Astellas and Zogenix hereby acknowledge and agree as follows: 
  

	 	•	 	 A list of the Selected Professionals (as referenced in Section 2 of the Amendment to Co-Promotion Agreement) is attached hereto as Exhibit A.

 This Memorandum of Exhibit may be signed in any number of counterparts, each of which shall be deemed to be an original and
all of which, when taken together, shall have the same effect as if the signatures thereon were on the same instrument. 
  

									
		 	Zogenix, Inc.	 		 		 	Astellas Pharma US, Inc.
					
		 	 /s/ Roger L. Hawley
	 		 		 	 /s/ M. Yoshida

		 	By: Roger L. Hawley	 		 		 	By: M. Yoshida
		 	Its: CEO	 		 		 	Its: President & CEO

  
 5 

 EXHIBIT A 
 [List of Selected Professionals attached] 

  
 6 

 [***] 
 Eighty Four (84) Pages omitted 
  

	***	Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted
portions. 

  
 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}]]